Manju L. Subramanian, MD
Associate Professor, Ophthalmology

Biography
Manju Subramanian is an Associate Professor at Boston University and Vice-Chairman of Faculty Affairs in the Department of Ophthalmology. She is an ophthalmic surgeon specializing in Vitreoretinal Disease, and is in academic practice at Boston Medical Center. Her primary areas of clinical interest include medical and surgical management of diabetic retinopathy, age-related macular degeneration, retinal detachments, hereditary retinal diseases, ocular inflammation, and ocular trauma. Dr. Subramanian graduated from the University of Missouri School of Medicine and completed her residency at the University of Kansas Medical Center in 2002. She completed a fellowship in Vitreoretinal Disease and Surgery at Tufts University School of Medicine and Ophthalmic Consultants of Boston in 2004.
Dr. Subramanian’s research interests include the study of eye fluid biomarkers as a potential diagnostic modality in Alzheimer’s Disease (AD). She is also active in clinical outcomes research in eye diseases such as age-related macular degeneration, diabetic retinopathy, and the role of anesthesia in eye surgery, with a particular emphasis on health disparities. She was Principal Investigator for a VA Boston sponsored head to head clinical trial comparing bevacizumab and ranibizumab in the treatment of age-related macular degeneration, and she was Principal Investigator for a study assessing the role of oral sedation in eye surgery. She is also a recent recipient of an R03 Grant Award by the National Institutes of Aging, in 2019, as the Principal Investigator of a study looking at protein biomarkers for AD in the eye.
In her leadership roles, she served as the Vice-Chair of Clinical Services within Ophthalmology for 8 years where she worked with hospital administrators in clinical operations, quality and compliance, and the creation of a new eye clinic. In 2017, she transitioned her role to Vice-Chair of Faculty Affairs where she currently works in a supportive role in the professional development and career engagement of the clinical faculty. Additionally, she serves on several institutional committees, including the Gender Equity Advisory Council, the Boston University Medical Group (BUMG) Research Committee, the BU Chobanian and Avedisian School of Medicine Promotion Criteria Working Group, and she is Chair of the BUMG Professional Development Committee. She is also a voting member of the BUMG Board of Trustees. She additionally serves on national committees, such as the International Meetings Committee for the American Academy of Ophthalmology (AAO), the Professional Development and Education Committee for the Association for Research in Vision and Ophthalmology (ARVO), and serves on several Special Emphasis Panel with the National Institutes of Health, and she is a past member of the Diversity Initiatives Committee for ARVO.
Education
- University of Missouri School of Medicine, MD
- University of Missouri, BS
Publications
- Published on 8/31/2023
Dia M, Albrecht MM, Sanayei N, Cabral H, Martin DC, Subramanian ML, Ness S, Siegel NH, Desai M, Chen X. Patient Satisfaction with the Hybrid Telemedicine Model for Ophthalmology. Telemed J E Health. 2023 Aug 31. PMID: 37651189.
Read at: PubMed - Published on 6/29/2023
Nguyen AH, Davoudi S, Dong K, Bains A, Ness S, Subramanian ML, Siegel NH, Chen X. Socioeconomic Disparities in Patients Receiving Intravitreal Injections for Age-Related Macular Degeneration Amid the COVID-19 Pandemic. J Vitreoretin Dis. 2023; 7(5):376-381. PMID: 37701269.
Read at: PubMed - Published on 4/8/2023
Zeng K, Cabral H, Ness S, Subramanian M, Siegel N, Chen X. Effect of Lens Status on Diabetic Vitreous Hemorrhage Resolution. J Vitreoretin Dis. 2023; 7(3):220-225. PMID: 37188215.
Read at: PubMed - Published on 3/8/2023
Hussain A, Sheikh Z, Subramanian M. The Eye as a Diagnostic Tool for Alzheimer's Disease. Life (Basel). 2023 Mar 08; 13(3). PMID: 36983883.
Read at: PubMed - Published on 3/8/2023
Hussain A, Sheikh Z, Subramanian M. The Eye as a Diagnostic Tool for Alzheimer's Disease. Life (Basel). 2023 Mar 08; 13(3). PMID: 36983883.
Read at: PubMed - Published on 1/4/2023
Xu J, Davoudi S, Yoon J, Chen X, Siegel NH, Subramanian ML, Ness S. Effect of race and ethnicity on surgical outcomes for rhegmatogenous retinal detachments. Can J Ophthalmol. 2023 Jan 04. PMID: 36610705.
Read at: PubMed - Published on 1/1/2023
Vig V, Garg I, Tuz-Zahra F, Xu J, Tripodis Y, Nicks R, Xia W, Alvarez VE, Alosco ML, Stein TD, Subramanian ML. Vitreous Humor Biomarkers Reflect Pathological Changes in the Brain for Alzheimer's Disease and Chronic Traumatic Encephalopathy. J Alzheimers Dis. 2023; 93(3):1181-1193. PMID: 37182888.
Read at: PubMed - Published on 12/31/2022
Prasad M, Xu J, Agranat JS, Xia W, Daley S, Ness S, Chen X, Siegel NH, Stein TD, Chung J, Subramanian ML. Upregulation of Neuroinflammatory Protein Biomarkers in Acute Rhegmatogenous Retinal Detachments. Life (Basel). 2022 Dec 31; 13(1). PMID: 36676067.
Read at: PubMed - Published on 12/23/2022
Chung J, Vig V, Sun X, Han X, O'Connor GT, Chen X, DeAngelis MM, Farrer LA, Subramanian ML. Genome-Wide Pleiotropy Study Identifies Association of PDGFB with Age-Related Macular Degeneration and COVID-19 Infection Outcomes. J Clin Med. 2022 Dec 23; 12(1). PMID: 36614910.
Read at: PubMed - Published on 12/14/2022
Prasad M, Paracha M, Goodman D, Cabral HJ, Christiansen SP, Subramanian ML. The Scholarly Impact of Student Authorship in Ophthalmology. Journal of Academic Ophthalmology. 2022; 15:e41-e45.
View 58 more publications: View full profile at BUMC